pctstg2_d pctstg34_d
Name
pctstg2_t
Label
Portion of sleep time spent in Stage 2 (split-night, treatment)
Units
percent
Type
numeric
Tags
% non-rapid eye movement sleep nrem psg
Visit number vs Portion of sleep time spent in Stage 2 (split-night, treatment)
N Mean StdDev Median Min Max Unknown Total
Baseline Visit 56 47.5 ± 16.0 47.0 15.7 100.0 317 373
Month 1 Follow-up Visit - - - - - - - -
Month 3 Follow-up Visit - - - - - - - -
Treatment arm vs Portion of sleep time spent in Stage 2 (split-night, treatment)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 56 47.5 ± 16.0 47.0 15.7 100.0 317 373
Lab 55 47.6 ± 16.2 47.2 15.7 100.0 131 186
Home 1 45.4 - 45.4 45.4 45.4 186 187
Age at baseline visit vs Portion of sleep time spent in Stage 2 (split-night, treatment)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 56 47.5 ± 16.0 47.0 15.7 100.0 317 373
20.0 to 37.0 years 11 41.7 ± 14.0 36.2 25.0 68.9 83 94
37.0 to 46.0 years 16 46.4 ± 13.1 47.2 15.7 67.1 77 93
46.0 to 55.0 years 14 51.9 ± 20.2 48.9 22.1 100.0 79 93
55.0 to 80.0 years 15 49.0 ± 16.0 53.3 16.2 69.9 78 93
Gender vs Portion of sleep time spent in Stage 2 (split-night, treatment)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 56 47.5 ± 16.0 47.0 15.7 100.0 317 373
Female 14 41.2 ± 10.0 39.7 25.0 59.8 134 148
Male 42 49.7 ± 17.1 49.7 15.7 100.0 183 225
Race vs Portion of sleep time spent in Stage 2 (split-night, treatment)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 56 47.5 ± 16.0 47.0 15.7 100.0 317 373
White 46 45.6 ± 13.9 45.2 16.2 78.1 212 258
Black 7 63.5 ± 20.0 66.2 37.6 100.0 80 87
Other 3 39.7 ± 21.2 47.2 15.7 56.1 25 28